SCRIPT presents at COMET and RCP Innovation in Medicine conferences

26th June 2018

The SCRIPT team have presented two posters this week showcasing how the project has embedded prescribing education in medical postgraduate curricula. This included a poster at the Communication, Medicine, and Ethics Conference (COMET) conference, held at the University of Birmingham from 25-27 June 2018.

At the same time, the team presented an electronic poster at the RCP’s Innovation in Medicine conference (25-26 June 2018). The conference was attended by SCRIPT’s Prof Robin Ferner, who also gave a talk on ‘Drug errors and the law.’ The e-poster is still currently available for viewing here.

Prof Ferner at RCP conference

Prof Ferner with the SCRIPT poster at the RCP Innovation in Medicine 2018 conference

 

 

 

 

 

 

 

 

SCRIPT Poster at the COMET 2018 conference

SCRIPT Poster at the COMET 2018 conference

More News

SCRIPT eLearning Shortlisted for Prestigious HSJ Patient Safety Award

SCRIPT eLearning is delighted to announce that it has been shortlisted in the ‘Patient Safety Education and Training’ category of the HSJ Patient Safety Awards 2026, recognising its ongoing contribution to improving safety in prescribing and medicines management. The...

Birmingham Education for Health Professional Conference 2026

The SCRIPT team was delighted to present a poster at the Birmingham Education for Health Professional Conference 2026, led by our Research Associate Divya Singh. The poster, titled "eLearning in Multidisciplinary Prescribing Education: A Longitudinal Evaluation...

New Modules Under Development

We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...

Updated module – Diabetes: Antihyperglycaemic Medicines

NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....